Neogenomics (NEO) EBT Growth (1y) (2011 - 2026)
Neogenomics (NEO) EBT Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 29,149.49 Bn | 29,149.03 Bn | 1.11 Bn | -161.54% |
| 2 | Thermo Fisher Scientific | 174.37 Bn | 171.12 Bn | 7.74 Bn | 7.04% |
| 3 | Danaher | 127.33 Bn | 121.64 Bn | 3.59 Bn | 9.39% |
| 4 | Idexx Laboratories | 44.68 Bn | 44.48 Bn | 722.74 Mn | 14.63% |
| 5 | Agilent Technologies | 36.54 Bn | 34.74 Bn | 990.00 Mn | 56.92% |
| 6 | Iqvia Holdings | 30.51 Bn | 28.53 Bn | 1.36 Bn | 1.55% |
| 7 | Natera | 30.00 Bn | 28.90 Bn | 696.04 Mn | -27.03% |
| 8 | Illumina | 24.61 Bn | 23.45 Bn | 721.00 Mn | -13.74% |
| 9 | Mettler Toledo International | 22.91 Bn | 22.85 Bn | 555.82 Mn | 3.82% |
| 10 | Neogenomics | 1.44 Bn | 1.29 Bn | 80.86 Mn | 31.49% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 31.49% |
| Dec 31, 2025 | 23.08% |
| Sep 30, 2025 | -47.85% |
| Jun 30, 2025 | -140.92% |
| Mar 31, 2025 | 7.31% |
| Dec 31, 2024 | -5.51% |
| Sep 30, 2024 | 16.79% |
| Jun 30, 2024 | 28.61% |
| Mar 31, 2024 | 17.91% |
| Dec 31, 2023 | 40.11% |
| Sep 30, 2023 | 45.86% |
| Jun 30, 2023 | 35.08% |
| Mar 31, 2023 | 36.57% |
| Dec 31, 2022 | 42.26% |
| Sep 30, 2022 | -71.01% |
| Jun 30, 2022 | -155.88% |
| Mar 31, 2022 | -151.49% |
| Dec 31, 2021 | -684.17% |
| Sep 30, 2021 | -1,142.75% |
| Jun 30, 2021 | 508.98% |